https://eyecon.bcst.md/ 2021-11-22T22:03:08+0000 weekly 1 https://eyecon.bcst.md/unsubscribe 2022-11-03T14:01:21+0000 weekly 0.8 https://eyecon.bcst.md/unsubscribe-confirmation 2022-11-03T13:59:25+0000 weekly 0.8 https://eyecon.bcst.md/medical-crossfire-expert-perspectives-in-sustained-delivery-of-anti-vegf-therapies-understanding-how-novel-treatments-may-shift-the-paradigm 2022-02-01T02:36:30+0000 weekly 0.8 https://eyecon.bcst.md/the-ophthalmology-times-eyecon-2021 2022-01-28T06:19:49+0000 weekly 0.8 https://eyecon.bcst.md/medical-crossfire-expert-perspectives-in-dry-eye-disease-analyzing-ded-in-the-digital-era-and-how-emerging-therapies-may-shift-the-treatment-paradigm 2022-03-17T18:34:15+0000 weekly 0.8 https://eyecon.bcst.md/clinical-consultations-expert-opinions-on-the-management-of-ocular-health-in-glaucoma-updating-the-armamentarium-with-advances-in-treatment 2022-03-17T20:44:56+0000 weekly 0.8 https://eyecon.bcst.md/the-ophthalmology-times-eyecon-2022 2022-10-05T14:47:18+0000 weekly 0.8 https://eyecon.bcst.md/advances-in-uveitic-macular-edema-the-future-of-treatment-for-patients-with-ume 2022-03-17T20:48:39+0000 weekly 0.8 https://eyecon.bcst.md/cases-and-conversations 2022-09-20T18:32:37+0000 weekly 0.8 https://eyecon.bcst.md/clinical-consultations-expert-perspectives-in-choroideremia-analyzing-the-potential-impact-of-gene-therapy 2022-03-17T20:53:19+0000 weekly 0.8 https://eyecon.bcst.md/clinical-briefings-expert-perspectives-in-cataract-surgery-advances-in-techniques-technologies-and-intraocular-lens-selection 2022-02-01T02:37:49+0000 weekly 0.8 https://eyecon.bcst.md/news/medical-crossfire-expert-perspectives-in-sustained-delivery-of-anti-vegf-therapies-understanding-how-novel-treatments-may-shift-the-paradigm 2022-01-28T01:25:38+0000 weekly 0.8